EP
RETA

Edgestream Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Edgestream Partners’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$374K Sell
2023
Q1 		$1.12M Sell
2022
Q4 		$1.51M Sell
2022
Q3 		$2.06M Buy